Abscopal Effect of SBRT in Combination With rhGM-CSF and INF-α 2b for Metastatic Thymic Epithelial Tumors
The purpose of this study is to determine whether stereotactic body radiotherapy (SBRT) combined with recombined human granulocyte-macrophage colony stimulating factor(rhGM-CSF) and Peginterferon alfa-2b is safe, effective in the treatment of patients with metastatic thymic epithelial tumors.
Thymic Epithelial Tumor
DRUG: rhGM-CSF，Peginterferon alfa-b2，radiation
The abscopal effect rate, The proportion of patients with an abscopal response assessed after the initiation of treatment, up to 12 months
Progression free survival, From the date of enrollment to the date of progression or death, up to 60 months|Overall survival, From the date of enrollment to the date of death or last follow-up, up to 60 months
The purpose of this study is to determine whether stereotactic body radiotherapy (SBRT) combined with recombined human granulocyte-macrophage colony stimulating factor(rhGM-CSF) and Peginterferon alfa-2b is safe, effective in the treatment of patients with metastatic thymic epithelial tumors.